Key Points

  • Neutron's slip to 2027 extends RKLB's profitability timeline to late 2027 at earliest for adjusted EBITDA, pushing positive cash flow beyond 2029—a meaningful execution risk that wasn't priced into earlier guidance.
  • Despite the setback, Electron rocket and space systems revenue surged 62% year-over-year to $234 million in Q2, demonstrating core business momentum that's being overshadowed by the headline delay.
  • At $55.24 (63% below the 52-week high), RKLB trades at 6.2x trailing revenue—cheaper than Intuitive Machines IRDM) at 4.8x but riskier given extended cash-burn runway and Neutron's critical path to investor credibility.

The Neutron Delay: Manufacturing Reality Collides with Ambition

Rocket Lab disclosed that carbon composite manufacturing defects in the first-stage propellant tank forced a push of Neutron's inaugural launch from Q4 2026 into 2027. On its surface, a six-to-nine-month slip in a heavy-lift development program is garden-variety aerospace delay. But the timing and admission reveal something harder: the company is hitting the wall between laboratory-proven Electron (a smaller, proven workhorse) and the exponentially harder jump to Neutron, a medium-lift vehicle designed to capture the $10+ billion addressable market for constellation resupply and deep-space missions.

The defect wasn't a design flaw—it was a manufacturing process failure in composite lamination. That's not reassuring. Composite dome fabrication is commodity-skill aerospace work; if RKLB's suppliers or internal production can't execute this at scale, Neutron's development costs will creep north and schedule risk will compound. Compare this to SpaceX's Starship, which has run at least 15 integrated flight tests already despite catastrophic teething pains. RKLB will have zero flight data on Neutron's booster and stage staging until late 2027 at the earliest—nearly a year behind the prior promise to the Street.

Management now pegs positive adjusted EBITDA for late 2027 as the earliest arrival point. Positive free cash flow has been pushed out to 2029. For a company burning cash and dependent on government contracts (primarily NASA Small Launch Vehicle and Space Force National Security Launch programs), that timeline is code for: we're funding Neutron's development through a combination of contract revenue, existing investor capital, and probably a capital raise down the line.

RKLB Analysis: Why Execution Risk Matters More Than Valuation

Rocket Lab is not in financial distress—not yet. Q2's 62% revenue growth and $234 million quarterly run-rate is real. The Electron rocket has become a predictable revenue generator; the Space Systems division (satellite bus and components) is growing and accretive. But growth without profitability in a capital-intensive, contract-dependent business is a leverage trap masquerading as upside.

The company burned roughly $80 million in operating cash in the first half of 2026 (extrapolated from recent quarterly trends). At that rate, even with Electron's steady output, RKLB needs either (1) a meaningful acceleration in Space Systems margins, (2) early Neutron customer deposits to offset development spend, or (3) additional equity capital to bridge the cash gap. Option 3 is the most likely path, which means shareholders will face dilution—and the stock will face headwinds—before Neutron ever lifts off.

Compare RKLB vs IRDM): Intuitive Machines has its own launch delays and cash-burn issues, but it's benefited from a sharper focus on a single mission (lunar lander) and a clearer path to government milestone payments. RKLB is trying to maintain Electron production, scale Space Systems, AND develop Neutron simultaneously. That's hard. It's not impossible—but it requires flawless execution in at least two of the three. The Neutron delay suggests execution is anything but flawless.

What RKLB Means for Investors in 2026

For growth-oriented portfolios, RKLB remains a sector play: commercial space is a multi-decade tailwind, and RKLB has real assets (launch licenses, government relationships, proven hardware). For value-oriented investors, the 65% markdown from the May peak is tempting—but it's tempting in the way a $3 poker chip is tempting when the pot is $100.

The core question is whether you believe RKLB can achieve profitability by late 2027 and hit the Neutron milestone without another major delay or capital raise that dilutes shareholders. Historically, aerospace first-flight delays are binary: they either resolve (SpaceX, Blue Origin) or they metastasize (Virgin Orbit, into insolvency). RKLB has more resources and customer traction than Virgin Orbit did, but fewer than SpaceX or Blue Origin. It's in the uncomfortable middle.

If you're evaluating top stock picks for beginners or scanning for value rebounds, RKLB is worth a [stock screener](/opportunities) pass. The risk/reward asymmetry has shifted unfavorably. The downside (another delay, forced capital raise, customer attrition) is now more visible than the upside (Neutron success, profitability acceleration). A better entry point—perhaps 40-50% below the May high—would offer more margin of safety.

For existing holders, the question is portfolio conviction. If RKLB is a 5% position in a diversified portfolio, you can afford to wait. If it's a 15%+ position betting on Neutron as a multi-bagger catalyst, you should trim and reassess once profitability timelines stabilize (probably after the next quarterly call).

The Bottom Line on RKLB

Rocket Lab's Neutron delay is not a death sentence, but it is a sentence: guilty of underestimating the gulf between small-rocket production and medium-lift development. The stock at $55 is cheaper than it was at $150, but it's not cheap enough yet to offset the extended cash-burn runway and renewed execution risk.

The Electron business is real. The Space Systems division is growing. But until Neutron flies successfully—and that's now at least 18 months away—RKLB remains a faith-based bet on management's ability to thread a narrow needle. For professional investors and traders, that's a passing. For what stocks are politicians buying in the space sector, watch the [insider trading tracker](/insider-trading) for any near-the-money calls or insider purchases; they'd be a vote of confidence. Until then, RKLB is a hold at best, a trim-on-strength candidate for most portfolios.

Explore more: RKLB Stock Analysis · IRDM Stock Analysis

StonkBuddy Scores

Every stock here has a live StonkBuddy score, signal and buy zone on its page: